Biotechnology Archives

Three strategies for successful ATMP facility design

Essential strategies to position your ATMP facility for success.

COVID-19 drug development strategies

All eyes are on those on the front lines seeking to develop and produce new drugs. There’s unprecedented pressure to offer both immediate treatments for those affected and long-term biotherapies and vaccines to prevent future epidemics.

Keys to accelerating your COVID-19 drug campaign

As SARS-CoV-2 moves fast through our global population, the pharmaceutical industry faces tremendous pressure to move even faster.

5 considerations for a commercial scale ATMP facility

Commercial scale is not far-off for advanced therapy medicinal product (ATMP) facilities.

How to deliver multi-product ATMP facilities for future flexibility

Manufacturers must produce a variety of ATMPs quickly and efficiently. Enter the multi-product ATMP facility.

Cell and gene therapy facility design molded by commercial biopharma experience

Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.

Choose your playing field: ATMP site selection

So you want to build a new facility for advanced therapy manufacture? Before you start building, there is one essential element that you need to get right: site selection.

Using digital tools to optimize facility design

Building information modeling software improves efficiency. Technology, like BIM, is changing more than just healthcare’s latest therapeutic modalities and pharmaceutical advances. It’s also disrupting the design and implementation of the facilities that create them.

Reducing waste with lean delivery in facility design and construction

Applying a lean delivery approach to the design and construction of new facilities can reduce waste, lower costs and improve speed to market.

Membrane-based reverse osmosis systems for WFI production

Water for injection (WFI) is used in the pharmaceutical industry to formulate parenteral drugs and for cleaning and other manufacturing operations. Reverse osmosis followed by a polishing step can be a more efficient and cost-effective solution for WFI production.

Biotechnology

Revolutionary insights for the next gen of medicine.